Episodes

23 minutes ago
Episode 64: A Tricky Treatment of Submacular Hemorrhages
23 minutes ago
23 minutes ago
In this our first Ophthalmologica special we review a number of papers from a special edition of Euretina's journal. Editor Professor Martin Zinkernagel is joined by Dr. Matias Iglicki to discuss the new findings

Tuesday Jun 17, 2025
Episode 63: Beyond Borders: Navigating Ophthalmology Fellowships Abroad
Tuesday Jun 17, 2025
Tuesday Jun 17, 2025
Ever considered broadening your professional horizons with an ophthalmology fellowship abroad? In this insightful episode, Dr. Peter Kiraly (Manchester Royal Eye Hospital) and Dr. Elon van Dijk (Leiden University Medical Center and Rotterdam Eye Hospital) share their personal journeys and practical advice from fellowships in the UK and Australia. Chaired by Jonathan McCrea

Thursday Jun 05, 2025
Episode 62: Bridging the Gap: How to Make Smarter Ocular Oncology Referrals
Thursday Jun 05, 2025
Thursday Jun 05, 2025
When should you refer and what should you include? Oncologists Hibba Quhill, Iwona Rospond-Kubiak, and Emine Kilic share practical, experience-based advice on improving referral pathways in ocular oncology. From triage strategies to imaging essentials, this episode covers what referring clinicians need to know to ensure timely and effective patient care

Wednesday Apr 30, 2025
Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Wednesday Apr 30, 2025
Wednesday Apr 30, 2025
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.

Sunday Apr 20, 2025
Sunday Apr 20, 2025
Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the importance of multidisciplinary collaboration in high-risk cases

Wednesday Apr 02, 2025
Episode 59: Demystifying Hyperreflective Foci in AMD: From Histology to Imaging
Wednesday Apr 02, 2025
Wednesday Apr 02, 2025
What are hyperreflective foci, and why do they matter in AMD? Prof. Stella Vujosevic is joined by Prof. Christine Curcio (University of Alabama at Birmingham) and Prof. Srinivas Sadda (Doheny Eye Institute, UCLA) to explore their significance—from donor eye histology to OCT imaging. They discuss key biomarkers, clinical implications, and how HRF can help guide treatment decisions in age-related macular degeneration

Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
What causes central serous chorioretinopathy (CSC), and how should it be managed? In this episode, experts Camiel Boon, Sobha Sivaprasad, and Gemmy Cheung discuss the latest insights into CSC and the pachychoroid spectrum, including new imaging findings, risk factors, and treatment options like PDT, laser, and anti-VEGF

Monday Mar 03, 2025
Monday Mar 03, 2025
Uveal melanoma remains a significant challenge, with genetic alterations playing a crucial role in treatment decisions. In this episode, Prof Jens Folke Kiilgaard (Denmark) and Dr Emine Kilic (Netherlands) join Prof Antonia Joussen (Germany) to explore why metastases persist despite primary tumor treatment, the limitations of checkpoint inhibitors, and the latest on Tebentafusp and Darovasertib. We also discuss the role of adjuvant and neoadjuvant therapies and emerging T-cell therapies. Join us for an insightful discussion on the future of uveal melanoma treatment

Tuesday Feb 11, 2025
Episode 56: Intraocular Tamponades and the Athens Special Focus Meeting
Tuesday Feb 11, 2025
Tuesday Feb 11, 2025
In this episode, Chair Alistair Laidlaw (UK) chats to Mario Romano (Italy) and Stratos Gotzaridis (Greece) about some of the considerations and complications surrounding the use of intraocular tamponades. They also discuss the upcoming Special Focus Meeting in Athens which will centre on vitreoretinal surgery (VR)

Wednesday Oct 16, 2024
Episode 55: Highlights from the Euretina Congress 2024 Part 3: Arshad Khanani
Wednesday Oct 16, 2024
Wednesday Oct 16, 2024
In this final episode of highlights from the Barcelona congress 2024, we’ll hear from Dr Arshad Khanani (USA) about clinical trials, long term-data and the importance of personalising the treatment to the patient